INM
InMed Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.38
+3.76%Jul 6, 2026, 22:20 UTC
InMed Pharmaceuticals and Mentari Therapeutics amended their merger agreement and filed a registration statement on Form S-4 with the SEC for their proposed all-stock merger.
Source:Jun 4, 2026, 21:00 UTC
InMed Pharmaceuticals received notice from Nasdaq that it has regained compliance with the minimum bid price requirement for continued listing.